ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Jay Luly on Q2 2020 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA)
Q2 2020 Earnings Conference Call
May 6, 2020 16:30 ET
Company Participants
Jennifer Viera - Senior Director, IR
Jay Luly - President & CEO
Paul Mellett - CFO
Nathalie Adda - SVP & CMO
Conference Call Participants
Yasmeen Rahimi - Roth Capital Partners
Akash Tewari - Wolfe Research
Presentation
Operator
Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Second Quarter Financial Results Conference Call. [Operator Instructions] There will be a question-and-answer session at the end of the prepared remarks. [Operator Instructions]
I would now like to turn the call over to